-
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
Monday, July 11, 2022 - 7:35am | 565MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) a pharmaceutical company specialized in precision-based cannabinoids, has entered into a share prchase agreement with OneLife Botanicals PTY for the sale of MediPharm Labs Australia Pty Ltd, a wholly-owned subsidiary of the company, for a...